Andrew Megill, University of Illinois Oratorio Society and UI Chamber Singers conductor
Meg Bragle, alto
Brian Giebler, tenor
Marques Jerrell Ruff, bass
Molly Madden, harp
Andrew Megill and the University of Illinois Oratorio Society and University of Illinois Chamber Singers join CUSO to perform Sir Michael Tippett’s A Child of Our Time, a moving work of depth and beauty. Written at the start of World War II, this landmark oratorio weaves American spirituals throughout a gripping musical tapestry, tracing an arc from oppression to a message of hope and reconciliation for humanity. Complementing this program, CUSO will also perform the scintillating Starburst, composed by rising star Jessie Montgomery, and Ennanga by William Grant Still, a showcase for solo harp, piano, and strings.
Tippett: A Child of Our Time
Tickets for this event will go on sale to the public at 10am on Tuesday, February 8, 2022. Tickets will be sold online only as mobile or print-at-home tickets and are not available for purchase by phone or at the Ticket Office counter. Before the on-sale date, please visit Krannert Center’s online ticket office to ensure you have or can create an active account. If you have any questions or need assistance, please feel welcome to contact the Ticket Office at 217.333.6280 or kran-tix [at] illinois.edu. All 2021-2022 ticket on-sale dates are now available. To learn about early ticket-buying opportunities, please contact Krannert Center’s Advancement team: 217.333.6700 or advancement [at] krannertcenter.illinois.edu.
In order to attend an in-theatre performance at Krannert Center for the Performing Arts, audience members must provide proof of full vaccination or a negative COVID-19 test. This change is occurring in response to increasingly strict contractual requirements of visiting artists, evolving performing arts industry standards, and audience expectations. At this time, face coverings are still required in indoor university spaces such as Krannert Center. Face coverings must be worn throughout any event or performance. For more information, please see our COVID-19 Safety Protocols page.